IP Library Assignment 064112/0527
Patent Assignment
Reel/Frame 064112/0527

Assignment of Assignor's Interest

Recorded: 2023-06-29 Pages: 7
Assignors
GUILD, BRAYDON CHARLES
Executed: 2014-02-07
DEROSA, FRANK
Executed: 2014-01-24
HEARTLEIN, MICHAEL
Executed: 2014-01-24
Assignee
SHIRE HUMAN GENETIC THERAPIES, INC.
300 SHIRE WAY, LEXINGTON, MASSACHUSETTS, 02421
Covered Properties (7)
Lipid Nanoparticle Compositions and Methods for Mrna Delivery
Application: 17/558,310 →
Publication: US 2022/0111072
Lipid Nanoparticle Compositions and Methods for Mrna Delivery
Application: 17/832,196 →
Publication: US 2022/0378939
Lipid Nanoparticle Compositions and Methods for Mrna Delivery
Application: 17/832,202 →
Publication: US 2022/0362406
Lipid Nanoparticle Compositions and Methods for Mrna Delivery
Application: 18/295,139 →
Publication: US 2023/0293723
Lipid Nanoparticle Compositions and Methods for Mrna Delivery
Application: 18/295,150 →
Publication: US 2023/0285592
Lipid Nanoparticle Compositions and Methods for Mrna Delivery
Application: 18/295,152 →
Publication: US 2023/0285593
Lipid Nanoparticle Compositions and Methods for Mrna Delivery
Application: 18/295,159 →
Publication: US 2023/0330262
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 5, 2022
From: GUILD, BRAYDON CHARLES; DEROSA, FRANK; HEARTLEIN, MICHAEL
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 059829/0444 →
Assignment of Assignor's Interest May 5, 2022
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: RANA THERAPEUTICS, INC.
Reel/Frame 059857/0537 →
Change of Name May 5, 2022
From: RANA THERAPEUTICS, INC.
To: TRANSLATE BIO, INC.
Reel/Frame 059857/0624 →
Assignment of Assignor's Interest Jun 29, 2023
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: RANA THERAPEUTICS, INC.
Reel/Frame 064163/0849 →
Change of Name Jun 29, 2023
From: RANA THERAPEUTICS, INC.
To: TRANSLATE BIO, INC.
Reel/Frame 064164/0055 →